Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Blood|July 23, 2011
Decreases in IL-7 levels during antiretroviral treatment of HIV infection suggest a primary mechanism of receptor-mediated clearanceJessica N Hodge, Sharat Srinivasula, Zonghui Hu, et al.
The Journal of Infectious Diseases|August 4, 2007
CD4+ T cell responses to interleukin-2 administration in HIV-infected patients are directly related to the baseline level of immune activationIrini Sereti, Peter Sklar, Meena S Ramchandani, et al.
The Journal of Infectious Diseases|September 13, 2014
Rifaximin has a marginal impact on microbial translocation, T-cell activation and inflammation in HIV-positive immune non-responders to antiretroviral therapy - ACTG A5286Allan R Tenorio, Ellen S Chan, Ronald J Bosch, et al.
Journal of Clinical and Translational Science|October 31, 2024
Preparing better: Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV) therapeutics trials lessons learned: A call to the futureStacey J Adam, Timothy G Buchman, Judith S Currier, et al.
Communications Medicine|September 1, 2022
Leveraging lessons learned from the COVID-19 pandemic for HIVThomas Calder, Tina Tong, Dale J Hu, et al.
Journal of Virology|April 8, 2011
CD4+ T cells, including Th17 and cycling subsets, are intact in the gut mucosa of HIV-1-infected long-term nonprogressorsEmily J Ciccone, Jamieson H Greenwald, Philip I Lee, et al.
The Journal of Infectious Diseases|August 8, 2008
CD4 T cell survival after intermittent interleukin-2 therapy is predictive of an increase in the CD4 T cell count of HIV-infected patientsSarah W Read, Richard A Lempicki, Michele Di Mascio, et al.
The Journal of Infectious Diseases|May 28, 2014
Sevelamer does not decrease lipopolysaccharide or soluble CD14 levels but decreases soluble tissue factor, low-density lipoprotein (LDL) cholesterol, and oxidized LDL cholesterol levels in individuals with untreated HIV infectionNetanya G Sandler, Xinyan Zhang, Ronald J Bosch, et al.
Plos One|March 8, 2014
Comparison of illumina and 454 deep sequencing in participants failing raltegravir-based antiretroviral therapyJonathan Z Li, Brad Chapman, Patrick Charlebois, et al.
The Lancet. HIV|October 14, 2022
Developing tuberculosis vaccines for people with HIV: consensus statements from an international expert panelMaurine D Miner, Mark Hatherill, Vidya Mave, et al.
Pageof 2